| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |